Beleodaq: payments to doctors
Payments that named Beleodaq as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.2M
- Providers
- 3,542
- Transactions
- 7,522
- Average per transaction
- $161
The per-transaction average — $161 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,542 providers the average total is $342, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Acrotech Biopharma Inc. | $899,574 | 74.2% |
| Acrotech Biopharma LLC | $243,759 | 20.1% |
| Aurobindo Pharma USA, Inc. | $66,427 | 5.5% |
| Spectrum Pharmaceuticals Inc. | $3,127 | 0.3% |